Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
Join the club for FREE to access the whole archive and other member benefits.
Founder, President, CEO, Secretary & Director, resTORbio, Inc.
Chen Schor founded resTORbio, Inc. Currently, Mr. Schor is President, CEO, Secretary & Director at this company. He is also on the board of Otic Pharma Ltd. He previously occupied the position of Chief Business Officer of EPIX Pharmaceuticals, Inc.
Visit website: https://www.bloomberg.com/profile/person/15112580
See also: resTORbio - Biopharmaceutical company developing therapeutics for aging-related diseases.
Details last updated 05-May-2020
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
Novartis sought to see whether giving low doses of everolimus to people over 65 increased their r...